首页> 美国卫生研究院文献>other >Design Synthesis and Application of Fluorine-Labeled Taxoids as 19F NMR Probes for the Metabolic Stability Assessment of Tumor-Targeted Drug Delivery Systems
【2h】

Design Synthesis and Application of Fluorine-Labeled Taxoids as 19F NMR Probes for the Metabolic Stability Assessment of Tumor-Targeted Drug Delivery Systems

机译:氟标记的类紫杉醇作为19F NMR探针的设计合成和应用用于评估肿瘤靶向药物递送系统的代谢稳定性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Novel tumor-targeting drug conjugates, BLT-F2 (>1) and BLT-S-F6 (>2), bearing a fluorotaxoid as the warhead, a mechanism-based self-immolative disulfide linker, and biotin as the tumor-targeting module, were designed and synthesized as 19F NMR probes. Fluorine atoms and CF3 groups were strategically incorporated into the conjugates to investigate the mechanism of linker cleavage and factors that influence their plasma and metabolic stability by real-time monitoring with 19F NMR. Time-resolved 19F NMR study on probe >1 disclosed a stepwise mechanism for release of a fluorotaxoid, which might not have been detected by other analytical methods. Probe >2 was designed to bear two CF3 groups in the taxoid moiety as “3-FAB” reporters for enhanced sensitivity and a polyethylene glycol oligomer insert to improve solubility. The clean analysis of the linker stability and reactivity of drug conjugates in blood plasma or cell culture media by HPLC and 1H NMR is troublesome, due to the overlap of key signals/peaks with background arising from highly complex ingredients in biological systems. Accordingly, the use of 19F NMR would provide a practical solution to this problem. In fact, our “3-FAB” probe >2 was proven to be highly useful to investigate the stability and reactivity of the self-immolative disulfide linker system in human blood plasma by 19F NMR. It has also been revealed that the use of polysorbate 80 as excipient for the formulation of probe >2 dramatically increases the stability of the disulfide linker system. This finding further indicates that the tumor-targeting drug conjugates with polysorbate 80/EtOH/saline formulation for in vivo studies would have high stability in blood plasma, while the drug release in cancer cells proceeds smoothly.
机译:新型靶向肿瘤的药物结合物BLT-F2(> 1 )和BLT-S-F6(> 2 ),以类紫杉醇为战斗部,这是一种基于机制的自我设计并合成了消旋二硫键,并以生物素为肿瘤靶向模块,作为 19 F NMR探针。通过 19 F NMR实时监测,将氟原子和CF3基团策略性地结合到缀合物中,以研究接头裂解的机理以及影响其血浆和代谢稳定性的因素。对探针> 1 进行时间分辨的 19 F NMR研究揭示了一种逐步释放氟类紫杉醇的机制,其他分析方法可能未检测到。探针> 2 被设计为在紫杉醇部分带有两个CF3基团,作为“ 3-FAB”报告基因,以提高灵敏度,并使用聚乙二醇低聚物插入物来提高溶解度。 HPLC和 1 H NMR对血浆或细胞培养基中药物偶联物的接头稳定性和反应性进行清晰的分析很麻烦,因为关键信号/峰与背景的重叠非常复杂生物系统中的成分。因此,使用 19 NMR可以为该问题提供实用的解决方案。实际上,我们的“ 3-FAB”探针> 2 被证明对于通过 19 2 可以显着提高二硫键系统的稳定性。该发现进一步表明,用于体内研究的靶向肿瘤的药物与聚山梨酯80 / EtOH /盐水的制剂在血浆中具有高稳定性,而在癌细胞中的药物释放则平稳进行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号